Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingda L Xie

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|December 14, 2017
Molecular Drug-Susceptibility Test for TuberculosisSoumitesh Chakravorty, Yingda L Xie, Susan E Dorman
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 9, 2026
The role of medical imaging in translational research into early pulmonary tuberculosisYingda L Xie, Iman Raza, Stephanus T Malherbe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2016
Reply to Tham et alYingda L Xie, Ray Y Chen, Irini Sereti, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 19, 2023
New approach to rifampicin stability and first-line anti-tubercular drug pharmacokinetics by UPLC-MS/MSMarta Karaźniewicz-Łada, Katarzyna Kosicka-Noworzyń, Prakruti Rao, et al.
Open Forum Infectious Diseases|November 6, 2019
Neurotuberculosis: Control of Steroid-Refractory Paradoxical Inflammatory Reaction With RuxolitinibYingda L Xie, Fanny Ita-Nagy, Ray Y Chen, et al.
Journal of Medical Microbiology|September 6, 2021
Sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testingPadmapriya Banada, David Elson, Naranjargal Daivaa, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Evaluation of sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testingPadmapriya Banada, David Elson, Naranjargal Daivaa, et al.
Diagnostics (Basel, Switzerland)|March 28, 2026
Divergent Evolution of Tuberculosis Lesions During Treatment: A Longitudinal CT-Based Analysis of Progression and Regression PatternsLiyi Qin, Jiaxin Jiang, Shiran Ma, et al.
Molecules (Basel, Switzerland)|January 23, 2024
Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in UrineMohamed Abouzid, Katarzyna Kosicka-Noworzyń, Marta Karaźniewicz-Łada, et al.
Aesthetic Surgery Journal|January 22, 2013
Mycobacterium chelonae facial infections following injection of dermal fillerJan M Rodriguez, Yingda L Xie, Kevin L Winthrop, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|December 14, 2017
Molecular Drug-Susceptibility Test for TuberculosisSoumitesh Chakravorty, Yingda L Xie, Susan E Dorman
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 9, 2026
The role of medical imaging in translational research into early pulmonary tuberculosisYingda L Xie, Iman Raza, Stephanus T Malherbe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2016
Reply to Tham et alYingda L Xie, Ray Y Chen, Irini Sereti, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 19, 2023
New approach to rifampicin stability and first-line anti-tubercular drug pharmacokinetics by UPLC-MS/MSMarta Karaźniewicz-Łada, Katarzyna Kosicka-Noworzyń, Prakruti Rao, et al.
Open Forum Infectious Diseases|November 6, 2019
Neurotuberculosis: Control of Steroid-Refractory Paradoxical Inflammatory Reaction With RuxolitinibYingda L Xie, Fanny Ita-Nagy, Ray Y Chen, et al.
Journal of Medical Microbiology|September 6, 2021
Sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testingPadmapriya Banada, David Elson, Naranjargal Daivaa, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Evaluation of sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testingPadmapriya Banada, David Elson, Naranjargal Daivaa, et al.
Diagnostics (Basel, Switzerland)|March 28, 2026
Divergent Evolution of Tuberculosis Lesions During Treatment: A Longitudinal CT-Based Analysis of Progression and Regression PatternsLiyi Qin, Jiaxin Jiang, Shiran Ma, et al.
Molecules (Basel, Switzerland)|January 23, 2024
Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in UrineMohamed Abouzid, Katarzyna Kosicka-Noworzyń, Marta Karaźniewicz-Łada, et al.
Aesthetic Surgery Journal|January 22, 2013
Mycobacterium chelonae facial infections following injection of dermal fillerJan M Rodriguez, Yingda L Xie, Kevin L Winthrop, et al.
Pageof 3